Cancer screening programs in South-east Asia and Western Pacific.
Breast cancer
Cancer screening
Cervical cancer
Colorectal cancer
Gastric cancer
Lung cancer
Organized screening
South-East Asia
Western pacific
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
18 Jan 2024
18 Jan 2024
Historique:
received:
13
04
2023
accepted:
14
11
2023
medline:
19
1
2024
pubmed:
19
1
2024
entrez:
18
1
2024
Statut:
epublish
Résumé
The burden of cancer can be altered by screening. The field of cancer screening is constantly evolving; from the initiation of program for new cancer types as well as exploring innovative screening strategies (e.g. new screening tests). The aim of this study was to perform a landscape analysis of existing cancer screening programs in South-East Asia and the Western Pacific. We conducted an overview of cancer screening in the region with the goal of summarizing current designs of cancer screening programs. First, a selective narrative literature review was used as an exploration to identify countries with organized screening programs. Second, representatives of each country with an organized program were approached and asked to provide relevant information on the organizations of their national or regional cancer screening program. There was wide variation in the screening strategies offered in the considered region with only eight programs identified as having an organized design. The majority of these programs did not meet all the essential criteria for being organized screening. The greatest variation was observed in the starting and stopping ages. Essential criteria of organized screening are missed. Improving organization is crucial to ensure that the beneficial effects of screening are achieved in the long-term. It is strongly recommended to consider a regional cancer screening network.
Sections du résumé
BACKGROUND
BACKGROUND
The burden of cancer can be altered by screening. The field of cancer screening is constantly evolving; from the initiation of program for new cancer types as well as exploring innovative screening strategies (e.g. new screening tests). The aim of this study was to perform a landscape analysis of existing cancer screening programs in South-East Asia and the Western Pacific.
METHODS
METHODS
We conducted an overview of cancer screening in the region with the goal of summarizing current designs of cancer screening programs. First, a selective narrative literature review was used as an exploration to identify countries with organized screening programs. Second, representatives of each country with an organized program were approached and asked to provide relevant information on the organizations of their national or regional cancer screening program.
RESULTS
RESULTS
There was wide variation in the screening strategies offered in the considered region with only eight programs identified as having an organized design. The majority of these programs did not meet all the essential criteria for being organized screening. The greatest variation was observed in the starting and stopping ages.
CONCLUSIONS
CONCLUSIONS
Essential criteria of organized screening are missed. Improving organization is crucial to ensure that the beneficial effects of screening are achieved in the long-term. It is strongly recommended to consider a regional cancer screening network.
Identifiants
pubmed: 38238704
doi: 10.1186/s12913-023-10327-8
pii: 10.1186/s12913-023-10327-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
102Informations de copyright
© 2024. The Author(s).
Références
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021;71(3).
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F et al. Cancer statistics in China, 2015. Cancer J Clin. 2016;66(2).
Matsuda T, Saika K. Cancer burden in Japan based on the latest cancer statistics: need for evidence-based cancer control programs. Annals of Cancer Epidemiology. 2018;2.
Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016;48(2).
Conforti C, Zalaudek I. Epidemiology and risk factors of Melanoma: a review. Dermatology Practical & Conceptual. 2021;11:e2021161S.
doi: 10.5826/dpc.11S1a161S
Cardoso R, Guo F, Heisser T, Hackl M, Ihle P, De Schutter H, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the Colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021;22(7):1002–1013d.
pubmed: 34048685
doi: 10.1016/S1470-2045(21)00199-6
Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Effectiveness of Breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. preventive services task force recommendation. Ann Intern Med. 2016;164(4):244–55.
pubmed: 26756588
doi: 10.7326/M15-0969
Gini A, Jansen EEL, Zielonke N, Meester RGS, Senore C, Anttila A, et al. Impact of Colorectal cancer screening on cancer-specific mortality in Europe: a systematic review. Eur J Cancer. 2020;127:224–35.
pubmed: 31932176
doi: 10.1016/j.ejca.2019.12.014
Zielonke N, Gini A, Jansen EEL, Anttila A, Segnan N, Ponti A, et al. Evidence for reducing cancer-specific mortality due to screening for Breast cancer in Europe: a systematic review. Eur J Cancer. 2020;127:191–206.
pubmed: 31932175
doi: 10.1016/j.ejca.2019.12.010
Jansen EEL, Zielonke N, Gini A, Anttila A, Segnan N, Vokó Z, et al. Effect of organised Cervical cancer screening on Cervical cancer mortality in Europe: a systematic review. Eur J Cancer. 2020;127:207–23.
pubmed: 31980322
doi: 10.1016/j.ejca.2019.12.013
Armaroli P, Villain P, Suonio E, Almonte M, Anttila A, Atkin WS et al. European Code against Cancer, 4th Edition: Cancer screening. Cancer Epidemiology. 2015;39.
Lynge E, Törnberg S, Von Karsa L, Segnan N, Van Delden JJM. Determinants of successful implementation of population-based cancer screening programmes. Eur J Cancer. 2012;48(5):743–8.
pubmed: 21788130
doi: 10.1016/j.ejca.2011.06.051
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: World Health Organization. ; 2021. Licence: CC BY-NC-SA 3.0 IGO.
Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K. The IARC Perspective on Colorectal Cancer Screening. N Engl J Med. 2018;378(18):1734–40.
pubmed: 29580179
doi: 10.1056/NEJMsr1714643
pmcid: 6709879
Bouvard V, Wentzensen N, MacKie A, Berkhof J, Brotherton J, Giorgi-Rossi P, et al. The IARC Perspective on Cervical Cancer Screening. Obstetrical and Gynecological Survey; 2022.
Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, et al. Breast-Cancer screening — viewpoint of the IARC Working Group. N Engl J Med. 2015;373(15):1479.
pubmed: 26444742
Hamashima C. Cancer screening guidelines and policy making: 15 years of experience in cancer screening guideline development in Japan. Jpn J Clin Oncol. 2018;48(3).
Garland SM, Cuzick J, Domingo EJ, Goldie SJ, Kim YT, Konno R et al. Recommendations for Cervical Cancer Prevention in Asia Pacific. Vaccine. 2008;26.
Wong MC, Ding H, Wang J, Chan PS, Huang J. Prevalence and risk factors of Colorectal cancer in Asia. Intest Res. 2019;17(3):317–29.
pubmed: 31085968
doi: 10.5217/ir.2019.00021
pmcid: 6667372
Sung JJY, Chiu HM, Lieberman D, et al. Third Asia-Pacific consensus recommendations on Colorectal cancer screening and postpolypectomy surveillance. Gut. 2022;71(11):2152–66.
pubmed: 36002247
doi: 10.1136/gutjnl-2022-327377
Chiu HM, Chen SLS, Yen AMF, Chiu SYH, Fann JCY, Lee YC, et al. Effectiveness of fecal immunochemical testing in reducing Colorectal cancer mortality from the one million Taiwanese screening program. Cancer. 2015;121(18):3221–9.
pubmed: 25995082
doi: 10.1002/cncr.29462
Yen AMF, Tsau HS, Fann JCY, Chen SLS, Chiu SYH, Lee YC, et al. Population-based Breast cancer screening with risk-based and universal mammography screening compared with clinical breast examination: a propensity score analysis of 1 429 890 Taiwanese women. JAMA Oncol. 2016;2(7):915–21.
pubmed: 27030951
doi: 10.1001/jamaoncol.2016.0447
Zhao Y, Bao H, Ma L, Song B, Di J, Wang L, et al. Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the Cervical cancer screening programme in China: a nationwide, population-based study. BMC Med. 2021;19(1):164.
pubmed: 34261463
doi: 10.1186/s12916-021-02026-0
pmcid: 8281674
Wang Y, Chen H, Li N, Ren J, Zhang K, Dai M, et al. Ultrasound for Breast cancer screening in high-risk women: results from a population-based cancer screening program in China. Front Oncol. 2019;9:286.
pubmed: 31069168
doi: 10.3389/fonc.2019.00286
pmcid: 6491776
Chen H, Li N, Ren J, Feng X, Lyu Z, Wei L, et al. Participation and yield of a population-based Colorectal cancer screening programme in China. Gut. 2019;68(8):1450–7.
pubmed: 30377193
doi: 10.1136/gutjnl-2018-317124
Chiu HM, Jen GHH, Wang YW, Fann JCY, Hsu CY, Jeng YC, et al. Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers. Gut. 2021;70(12):2321–9.
pubmed: 33495268
doi: 10.1136/gutjnl-2020-322545
World Health Organization Member States. https://www.who.int/about/who-we-are/regional-offices . Accessed May 13 2022.
Sarfati D, Dyer R, Sam FAL, Barton M, Bray F, Buadromo E, et al. Cancer control in the Pacific: big challenges facing small island states. Lancet Oncol. 2019;20(9):e475–92.
pubmed: 31395476
doi: 10.1016/S1470-2045(19)30400-0
pmcid: 7746436
Zhang L, Carvalho AL, Mosquera I, Wen T, Lucas E, Sauvaget C, et al. An international consensus on the essential and desirable criteria for an ‘organized’ cancer screening programme. BMC Med. 2022;20(1):101.
pubmed: 35317783
doi: 10.1186/s12916-022-02291-7
pmcid: 8941752
Overview of New. Zealand Cancer Screening Programs. www.timetoscreen.nz. Accessed May 12 2022.
Huang CH, Lo YJ, Kuo KM, Lu IC, Wu H, Hsieh MT, et al. Health literacy and cancer screening behaviors among community-dwelling female adults in Taiwan. Women Health. 2021;61(5):408–19.
pubmed: 33902386
doi: 10.1080/03630242.2021.1917477
STRC Guidelines 2019. https://www.moh.gov.sg/docs/librariesprovider5/licensing-terms-and-conditions/moh-cir-no-08_2019_6mar19_screening.pdf . Accessed May 13 2022.
National Cancer Control Programme. 2018–2022. https://www.nci.go.th/th/New_web/index.html . Accessed May 13 2022.
Overview of Australian Cancer Screening Programs. http://www.cancerscreening.gov.au/ . Accessed May 13 2022.
Min KJ, Lee YJ, Suh M, Yoo CW, Lim MC, Choi J, et al. The Korean guideline for Cervical cancer screening. J Gynecol Oncol. 2015;26(3):232–9.
pubmed: 26197860
doi: 10.3802/jgo.2015.26.3.232
pmcid: 4510341
National Cancer Screening Programs. https://www.ncc.re.kr/main.ncc?uri=english/sub04_ControlPrograms03 . Accessed may 13 2022.
Insamran W, Sangrajrang S. National cancer control program of Thailand. Asian Pac J Cancer Prev. 2020;21(3):577–82.
pubmed: 32212781
doi: 10.31557/APJCP.2020.21.3.577
pmcid: 7437310
Natonal Strategic Plan. - Portal Rasmi Kementerian Kesihatan Malaysia. moh.gov.my. Accessed May 13 2022.
Kao SY en, Lim E. An overview of detection and screening of Oral cancer in Taiwan. Chin J Dent Res. 2015;18(1):7–12.
pubmed: 25815378
Kim Y. Implementation of organized Lung cancer screening program in Korea (Abstract). Ann Oncol. 2019;30.
Kwon JW, Tchoe HJ, Lee J, Suh JK, Lee JH, Shin S. The impact of national surveillance for Liver cancer: results from real-world setting in Korea. Gut Liver. 2020;14(1):108–16.
pubmed: 30974929
doi: 10.5009/gnl18522
Basu P, Ponti A, Anttila A, Ronco G, Senore C, Vale DB, et al. Status of implementation and organization of cancer screening in the European Union Member States—Summary results from the second European screening report. Int J Cancer. 2018;142(1):44–56.
pubmed: 28940326
doi: 10.1002/ijc.31043
Ko KP, Shin A, Cho S, Park SK, Yoo KY. Environmental contributions to gastrointestinal and Liver cancer in the Asia–Pacific region. J Gastroenterol Hepatol. 2018;33(1):111–20.
pubmed: 28960448
doi: 10.1111/jgh.14005
Moss SF. The clinical evidence linking Helicobacter pylori to Gastric Cancer. Cell Mol Gastroenterol Hepatol. 2016;3(2):183–91.
pubmed: 28275685
doi: 10.1016/j.jcmgh.2016.12.001
pmcid: 5331857
Sugano K. Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol. 2015;29(6):895–905.
pubmed: 26651251
doi: 10.1016/j.bpg.2015.09.013
Hamashima C. Forthcoming step in gastric Cancer Prevention: how can Risk Stratification be combined with endoscopic screening for gastric Cancer? Gut Liver. 2022;16(6):811–24.
pubmed: 35314519
doi: 10.5009/gnl210313
pmcid: 9668507
Conran CA, Shi Z, Resurreccion WK, Na R, Helfand BT, Genova E, et al. Assessing the clinical utility of genetic risk scores for targeted cancer screening. J Transl Med. 2021;19(1):41.
pubmed: 33482857
doi: 10.1186/s12967-020-02699-w
pmcid: 7821544
Naber SK, Kundu S, Kuntz KM, Dotson WD, Williams MS, Zauber AG et al. Cost-effectiveness of risk-stratified Colorectal cancer screening based on polygenic risk: current status and future potential. JNCI Cancer Spectrum. 2020;4(1).
Chen LS, Yen AMF, Chiu SYH, Liao CS, Chen HH. Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based Colorectal cancer screening cohort. Lancet Oncol. 2011;12(6):551–8.
pubmed: 21592859
doi: 10.1016/S1470-2045(11)70101-2
Lansdorp-Vogelaar I, Meester R, de Jonge L, Buron A, Haug U, Senore C. Risk-stratified strategies in population screening for Colorectal cancer. Int J Cancer. 2022;150(3):397–405.
pubmed: 34460107
doi: 10.1002/ijc.33784
Dorji T, Tshomo U, Gyamtsho S, Tamang ST, Wangmo S, Pongpirul K. Gender-neutral HPV elimination, Cervical cancer screening, and treatment: experience from Bhutan. Int J Gynecol Obstet. 2021;156(3):425–9.
doi: 10.1002/ijgo.13728
Rich JS, Black WC. When should we stop screening? Eff Clin Pract. 2000;3(2):78–84.
pubmed: 10915327
Sivaram S, Majumdar G, Perin D, Nessa A, Broeders M, Lynge E, et al. Population-based cancer screening programmes in low-income and middle-income countries: regional consultation of the International Cancer Screening Network in India. Lancet Oncol. 2018;19(2):e113–22.
pubmed: 29413465
doi: 10.1016/S1470-2045(18)30003-2
pmcid: 5835355
Mandal R, Basu P. Cancer screening and early diagnosis in low and middle income countries: current situation and future perspectives. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2018;61(12):1505–12.
pubmed: 30353287
doi: 10.1007/s00103-018-2833-9
Zhao S, Huang L, Basu P, Domingo EJ, Supakarapongkul W, Ling WY, et al. Cervical cancer burden, status of implementation and challenges of Cervical cancer screening in Association of Southeast Asian Nations (ASEAN) countries. Cancer Lett. 2022;525:22–32.
pubmed: 34728309
doi: 10.1016/j.canlet.2021.10.036
Mittra I, Mishra GA, DIkshit RP, Gupta S, Kulkarni VY, Shaikh HKA, et al. Effect of screening by clinical breast examination on Breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai. BMJ. 2021;372:n256.
pubmed: 33627312
doi: 10.1136/bmj.n256
pmcid: 7903383
Global strategy to. Accelerate the elimination of Cervical cancer as a public health problem. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.
Australian Institute of Health and Welfare. Analysis of cancer outcomes and screening behaviour for national cancer screening programs in Australia. Cancer series no. 111. Cat. No. CAN 115. Canberra: AIHW; 2018.
Jung M. National Cancer Screening Programs and evidence-based Healthcare Policy in South Korea. Health Policy. 2015;119(1):26–32.
pubmed: 25220569
doi: 10.1016/j.healthpol.2014.08.012
Lee S, Jun JK, Suh M, Park B, Noh DK, Jung KW, et al. Gastric cancer screening uptake trends in Korea: results for the national cancer screening program from 2002 to 2011. Medicine. 2015;94(8):e533.
pubmed: 25715251
doi: 10.1097/MD.0000000000000533
pmcid: 4554157
Hur Byul. Cost-effectiveness analysis of Colorectal Cancer Screening in Korean General Population. Korean J Family Med. 2004;25(4).
Ko MJ, Kim J, Kim Y, Lee YJ, Hong SR, Lee JK. Cost-effectiveness analysis of Cervical cancer screening strategies based on the papanicolaou smear test in Korea. Asian Pac J Cancer Prev. 2015;16(6):2317–22.
pubmed: 25824757
doi: 10.7314/APJCP.2015.16.6.2317
Nguyen CP, Adang EMM. Cost-effectiveness of Breast cancer screening using mammography in Vietnamese women. PLoS ONE. 2018;13(3):e0194996.
pubmed: 29579131
doi: 10.1371/journal.pone.0194996
pmcid: 5868837
Tsoi KKF, Ng SSM, Leung MCM. J.y.sung J. cost-effectiveness analysis on screening for colorectal Neoplasm and management of Colorectal cancer in Asia. Aliment Pharmacol Ther. 2008;28(3).
Cenin DR, St John DJB, Ledger MJN, Slevin T, Lansdorp-Vogelaar I. Optimising the expansion of the National Bowel Cancer Screening Program. Med J Aust. 2014;201(8):456–61.
pubmed: 25332032
doi: 10.5694/mja13.00112
pmcid: 4412258
Lew J, Bin, Feletto E, Wade S, Caruana M, Kang YJ, Nickson C, et al. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates. Public Health Res Pract. 2019;29(2):29121913.
pubmed: 31384886
doi: 10.17061/phrp2921913
Termrungruanglert W, Khemapech N, Tantitamit T, Sangrajrang S, Havanond P, Laowahutanont P. Cost-effectiveness analysis study of HPV testing as a primary Cervical cancer screening in Thailand. Gynecol Oncol Rep. 2017;22:58–63.
pubmed: 29034308
doi: 10.1016/j.gore.2017.09.007
pmcid: 5633754
Phisalprapa P, Supakankunti S, Chaiyakunapruk N. Cost-effectiveness and budget impact analyses of Colorectal cancer screenings in a low- and middle-income country: example from Thailand. J Med Econ. 2019;22(12):1351–61.
pubmed: 31560247
doi: 10.1080/13696998.2019.1674065
Ohnuki K, Kuriyama SS, Shoji N, Nishino Y, Tsuji I, Ohuchi N. Cost-effectiveness analysis of screening modalities for Breast cancer in Japan with special reference to women aged 40–49 years. Cancer Sci. 2006;97(11):1242–7.
pubmed: 16918992
doi: 10.1111/j.1349-7006.2006.00296.x
Wong SS, Leong APK, Leong TY. Cost-effectiveness analysis of Colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach. Stud Health Technol Inform. 2004;107:104–10.
pubmed: 15360784
Dan YY, Chuah BYS, Koh DCS, Yeoh KG. Screening based on risk for Colorectal Cancer is the most cost-effective Approach. Clin Gatroenterol Hepatol. 2012;10(3):266–71.
doi: 10.1016/j.cgh.2011.11.011
McLeod M, Kvizhinadze G, Boyd M, Barendregt J, Sarfati D, Wilson N, et al. Colorectal cancer screening: how health gains and cost-effectiveness vary by ethnic group, the impact on health inequalities, and the optimal age range to screen. Cancer Epidemiol Biomarkers Prev. 2017;26(9):1391–400.
pubmed: 28626068
doi: 10.1158/1055-9965.EPI-17-0150
Chen Y, Watson TR, Criss SD, Eckel A, Palazzo L, Sheehan DF, et al. A simulation study of the effect of Lung cancer screening in China, Japan, Singapore, and South Korea. PLoS ONE. 2019;14(7):e0220610.
pubmed: 31361789
doi: 10.1371/journal.pone.0220610
pmcid: 6667161
Hussain SA, Sullivan R. Cancer control in Bangladesh. Jpn J Clin Oncol. 2013;43(12):1159–69.
pubmed: 24163419
doi: 10.1093/jjco/hyt140
pmcid: 3842101
IARC Handbooks of Cancer Prevention. Colorectal Cancer Screening. 2019. Volume 17.
Rabeneck L, Lansdorp-Vogelaar I. Assessment of a cancer screening program. Best Pract Res Clin Gastroenterol. 2015;29(6):979–85.
pubmed: 26651258
doi: 10.1016/j.bpg.2015.09.009
Hussain SA, Sullivan R. Cancer control in Bangladesh. Jpn J Clin Oncol. 2013;43(12):1159-69.
Basu P, Nessa A, Majid M, Rahman JN, Ahmed T. Evaluation of the National Cervical Cancer Screening Programme of Bangladesh and the formulation of quality assurance guidelines. J Fam Plann Reprod Health Care. 2010;36(3):131–4.
pubmed: 20659365
doi: 10.1783/147118910791749218
Baussano I, Tshomo U, Clifford GM, Tenet V, Tshokey T, Franceschi S. Cervical cancer screening program in Thimphu, Bhutan: Population coverage and characteristics associated with screening attendance. BMC Womens Health. 2014;14(1):147.
pubmed: 25433538
doi: 10.1186/s12905-014-0147-0
pmcid: 4258285
Cervical Cancer Screening Manuel. 2014 Bhutan. http://www.moh.gov.bt/wp-content/uploads/ict-files/2014/11/Cervical-Cancer-screening-manual-2014.pdf . Accessed May 13 2022.
Operational Framework Management of Common Cancer. 2016. https://main.mohfw.gov.in/sites/default/files/ Operational Framework Management of Common Cancers_1.pdf. Accessed May 13 2022.
Rajaraman P, Anderson BO, Basu P, Belinson JL, D’Cruz A, Dhillon PK, et al. Recommendations for screening and early detection of common cancers in India. Lancet Oncol. 2015;16(7):e352–61.
pubmed: 26149887
doi: 10.1016/S1470-2045(15)00078-9
Mishra GA, Dhivar HD, Gupta SD, Kulkarni SV, Shastri SS. A population-based screening program for early detection of common cancers among women in India - Methodology and interim results. Indian J Cancer. 2015;52(1):139–45.
pubmed: 26838003
doi: 10.4103/0019-509X.175581
Anwar SL, Tampubolon G, Van Hemelrijck M, Hutajulu SH, Watkins J, Wulaningsih W. Determinants of cancer screening awareness and participation among Indonesian women. BMC Cancer. 2018;18(1):208.
pubmed: 29506486
doi: 10.1186/s12885-018-4125-z
pmcid: 5838961
Wahidin M. Overview of ten years (2007–2016) cervical and Breast Cancer screening program in Indonesia. J Global Oncol. 2018;4(Supplement 2).
Koo JH, Leong RWL, Ching J, Yeoh KG, Wu DC, Murdani A, et al. Knowledge of, attitudes toward, and barriers to participation of Colorectal cancer screening tests in the Asia-Pacific region: a multicenter study. Gastrointest Endosc. 2012;76(1):126–35.
pubmed: 22726471
doi: 10.1016/j.gie.2012.03.168
Basu P, Hassan S, Fileeshia F, Mohamed S, Nahoodha A, Shiuna A, et al. Knowledge, attitude and practices of women in Maldives related to the risk factors, prevention and early detection of Cervical cancer. Asian Pac J Cancer Prev. 2014;15(16):6691–5.
pubmed: 25169510
doi: 10.7314/APJCP.2014.15.16.6691
Darj E, Chalise P, Shakya S. Barriers and facilitators to Cervical cancer screening in Nepal: a qualitative study. Sex Reprod Healthc. 2019;20:20–6.
pubmed: 31084813
doi: 10.1016/j.srhc.2019.02.001
National guideline on cancer early detection and referal pathways printed book. (Sri Lanka). https://nccp.health.gov.lk/en . Accessed May 13 2022.
Jayarajah U, Abeygunasekera AM. Cancer services in Sri Lanka: current status and future directions. J Egypt natl Canc Inst. 2021;33(1):13.
pubmed: 34081229
doi: 10.1186/s43046-021-00070-8
National Health Screening Guideline on Noncommunicable Diseases (NCDs). http://www.moh.gov.bn/SharedDocuments/MOH_NationalHealthScreeningGuidelineonNCDs_23Jul2020.pdf . Accessed May 13 2020.
Vorn R, Ryu E, Srun S, Chang S, Suh I, Kim W. Breast and Cervical cancer screening for risk assessment in Cambodian women. J Obstet Gynaecol. 2020;40(3):395–400.
pubmed: 32091288
doi: 10.1080/01443615.2019.1633515
Shi JF, Cao M, Wang Y, Bai FZ, Lei L, Peng J, et al. Is it possible to halve the incidence of Liver cancer in China by 2050? Int J Cancer. 2021;148(5):1051–65.
pubmed: 32997794
doi: 10.1002/ijc.33313
Yang H, Li SP, Chen Q, Morgan C. Barriers to Cervical cancer screening among rural women in eastern China: a qualitative study. BMJ Open. 2019;9(3):e026413.
pubmed: 30872552
doi: 10.1136/bmjopen-2018-026413
pmcid: 6429857
Pan KF, Zhang L, Gerhard M, Ma JL, Liu WD, Ulm K, et al. A large randomised controlled intervention trial to prevent gastric cancer by eradication of Helicobacter pylori in Linqu County, China: baseline results and factors affecting the eradication. Gut. 2016;65(1):9–18.
pubmed: 25986943
doi: 10.1136/gutjnl-2015-309197
Chen R, Liu Y, Song G, Li B, Zhao D, Hua Z, et al. Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study. Gut. 2021;70(2):251–60.
pubmed: 32241902
Cao M, Li H, Sun D, He S, Yu Y, Li J, et al. Cancer screening in China: the current status, challenges, and suggestions. Cancer Lett. 2021;506:120–7.
pubmed: 33684533
doi: 10.1016/j.canlet.2021.02.017
Lee M, Mariapun S, Rajaram N, Teo SH, Yip CH. Performance of a subsidised mammographic screening programme in Malaysia, a middle-income Asian country. BMC Public Health. 2017;17(1):127.
pubmed: 28129762
doi: 10.1186/s12889-017-4015-3
pmcid: 5273834
Hassan MRA, Leong TW, Andu DFO, Hat H, Nik Mustapha NR. Evaluation of a colorectal carcinoma screening program in Kota Setar and Kuala Muda districts, Malaysia. Asian Pac J Cancer Prev. 2016;17(2):569–73.
pubmed: 26925645
doi: 10.7314/APJCP.2016.17.2.569
https://www.borgenmagazine.com/increasing-cervical-cancer-screenings-mongolia/ . Accessed May 13 2022.
Cancer Prevention Guidelines. http://www.philcancer.org.php/educational/cancer-prevention . Accessed May 13 2022.
Chiu HM, Su CW, Hsu WF, Jen GHH, Hsu CY, Chen SLS, et al. Mitigating the impact of COVID-19 on Colorectal cancer screening: Organized service screening perspectives from the Asia-Pacific region. Prev Med. 2021;151:106622.
pubmed: 34044024
doi: 10.1016/j.ypmed.2021.106622
pmcid: 8443175
Chuang SL, Su WWY, Chen SLS, Yen AMF, Wang CP, Fann JCY, et al. Population-based screening program for reducing Oral cancer mortality in 2,334,299 Taiwanese cigarette smokers and/or betel quid chewers. Cancer. 2017;123(9):1597–609.
pubmed: 28055109
doi: 10.1002/cncr.30517
Pham T, Bui L, Kim G, Hoang D, Tran T, Hoang M. Cancers in Vietnam—Burden and Control efforts: a narrative scoping review. Cancer Control. 2019;26(1).